A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
dc.contributor.author | Fisker, Ane B | |
dc.contributor.author | Nebie, Eric | |
dc.contributor.author | Schoeps, Anja | |
dc.contributor.author | Martins, Cesario | |
dc.contributor.author | Rodrigues, Amabelia | |
dc.contributor.author | Zakane, Alphonse | |
dc.contributor.author | Kagone, Moubassira | |
dc.contributor.author | Byberg, Stine | |
dc.contributor.author | Thysen, Sanne M | |
dc.contributor.author | Tiendrebeogo, Justin | |
dc.contributor.author | Coulibaly, Boubacar | |
dc.contributor.author | Sankoh, Osman | |
dc.contributor.author | Becher, Heiko | |
dc.contributor.author | Whittle, Hilton C | |
dc.contributor.author | van der Klis, Fiona R M | |
dc.contributor.author | Benn, Christine S | |
dc.contributor.author | Sie, Ali | |
dc.contributor.author | Müller, Olaf | |
dc.contributor.author | Aaby, Peter | |
dc.date.accessioned | 2018-03-08T11:40:02Z | |
dc.date.available | 2018-03-08T11:40:02Z | |
dc.date.issued | 2017-11-21 | |
dc.identifier.citation | A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels. 2017 Clin. Infect. Dis. | en |
dc.identifier.issn | 1537-6591 | |
dc.identifier.pmid | 29177407 | |
dc.identifier.doi | 10.1093/cid/cix1033 | |
dc.identifier.uri | http://hdl.handle.net/10029/621557 | |
dc.description.abstract | Besides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels. | |
dc.language.iso | en | en |
dc.rights | info:eu-repo/semantics/closedAccess | en |
dc.title | A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels. | en |
dc.type | Article | en |
dc.identifier.journal | Clin Infect Dis 2018; 66(10):1573-80 | en |
html.description.abstract | Besides protecting against measles, measles vaccine (MV) may have beneficial non-specific effects. We tested the effect of an additional early MV on mortality and measles antibody levels. |